Table 3.
Clinicopathological features of HOXA13 in LUSC based on TCGA
| Clinicopathological features | N | HOXA13 expression | |||
|---|---|---|---|---|---|
|
| |||||
| Mean ± SD | t (or F) | P value | |||
| Tissues | Cancer | 470 | 6.387±2.097 | -19.232 | <0.001 |
| Non-cancerous | 8 | 1.157±0.719 | |||
| Race | White | 331 | 5.465±2.051 | F=3.892 | 0.021 |
| Asian | 9 | 4.264±2.662 | |||
| Black | 28 | 6.304±1.585 | |||
| AGE | ≥60 years | 198 | 6.341±2.105 | -0.345 | 0.730 |
| <60 years | 40 | 6.470±2.377 | |||
| Gender | Male | 349 | 6.471±2.081 | 1.475 | 0.141 |
| Female | 121 | 6.145±2.133 | |||
| Status | Dead | 201 | 6.272±2.154 | -1.030 | 0.304 |
| Alive | 269 | 6.473±2.054 | |||
| Neoplasm Cancer Status | With tumor | 105 | 6.247±2.268 | -0.678 | 0.500 |
| Tumor free | 299 | 6.410±2.0725 | |||
| Stage | I-II | 382 | 6.492±2.040 | 1.798 | 0.073 |
| III-IV | 84 | 6.043±2.211 | |||
| M | M0 | 390 | 5.549±2.069 | F=0.224 | 0.800 |
| M1 | 4 | 6.041±2.528 | |||
| MX | 73 | 5.431±1.974 | |||
| T | T1-T2 | 385 | 6.432±2.015 | 0.881 | 0.380 |
| T3-T4 | 85 | 6.182±2.439 | |||
| N | N0-N1 | 424 | 5.525±2.050 | F=2.566 | 0.078 |
| N2-N3 | 45 | 5.780±1.974 | |||
| NX | 4 | 3.369±2.596 | |||
| Recurrence | Distant metastasis | 36 | 5.524±2.346 | F=0.565 | 0.571 |
| New primary tumor | 12 | 5.457±2.031 | |||
| Locoregional recurrence | 30 | 4.959±2.135 | |||
Note: t, Student’s t-test; F, one-way ANOVA; SD, standard deviation; T, tumor; N, lymph node; M, metastasis.